Biggest changeFor so long as we are an emerging growth company, we will not be required to: ● comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis); ● have an auditor report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act; ● submit certain executive compensation matters to stockholder advisory votes, such as “say-on-pay,” “say-on-frequency” and pay ratio; and ● disclose certain executive compensation-related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. 34 In addition, Section 107 of the JOBS Act also provides that an EGC can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards.
Biggest changeAs an emerging growth company, we are not required to: ● comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act regarding internal control over financial reporting; ● comply with any requirement that may be adopted by the Public Company Accounting Oversight Board (PCAOB) regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis); ● provide certain executive compensation disclosures required of larger public companies; or ● hold advisory votes on executive compensation matters, such as “say-on-pay,” “say-on-frequency,” and “say-on-golden parachutes.” In addition, Section 107 of the JOBS Act provides that an emerging growth company may take advantage of an extended transition period for complying with new or revised accounting standards.
These estimates are based on amounts earned or expected to be claimed by customers on the related sales, and are therefore recorded to the respective net revenue, trade accounts receivable, and sales program liability accounts. We may offer short-term sales program incentives, which include sell-through promotions and price concessions or price reductions.
These estimates are based on amounts earned or expected to be claimed by customers on the related sales, and are therefore recorded to the respective net revenue, trade accounts receivable, and sales program liability accounts. We may offer short-term sales incentives, which include sell-through promotions and price concessions or price reductions.
The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, stockholders’ equity, revenues and expenses, as well as related disclosures of contingent assets and liabilities. We base our estimates on historical experience and various other assumptions that management believes to be reasonable under the circumstances.
The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, stockholders’ equity, revenues, and expenses, as well as the related disclosures of contingent assets and liabilities. Management bases its estimates on historical experience and on various other assumptions that management believes to be reasonable under the circumstances.
In addition, the Company’s independent registered public accounting firm, in its report on the Company’s consolidated financial statements for the year ended December 31, 2024, expressed substantial doubt about the Company’s ability to continue as a going concern. At December 31, 2024, we had cash and cash equivalents on hand in the amount of $7.7 million.
In addition, the Company’s independent registered public accounting firm expressed substantial doubt about the Company’s ability to continue as a going concern in its report on the Company’s financial statements for the year ended December 31, 2025. At December 31, 2025, the Company had approximately $1.3 million of cash and cash equivalents.
Critical Accounting Policies and Estimates Our discussion and analysis of our results of operations, financial condition and liquidity are based upon our consolidated financial statements, which have been prepared and audited in accordance with GAAP.
Critical Accounting Policies and Estimates Our discussion and analysis of our results of operations, financial condition, and liquidity are based upon our financial statements, which have been prepared and audited in accordance with U.S. generally accepted accounting principles (“GAAP”).
The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an assessment of the specific terms of the warrants and the guidance provided by the Financial Accounting Standards Board (FASB) in ASC 480, Distinguishing Liabilities from Equity (ASC 480) and ASC 815, Derivatives and Hedging (ASC 815).
Warrant Accounting The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an evaluation of the specific terms of the warrants and the applicable guidance in ASC 480, Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging.
The increase in net sales was from the introduction of our Newton Motion driver shaft product line in November 2023, and our Newton Motion fairway shaft product line in April 2024.
The increase in net sales was primarily driven by the introduction and expansion of the Newton Motion shaft product line. The Company launched the Newton Motion driver shaft in November 2023 and the Newton Motion fairway wood shaft in April 2024.
We would cease to be an emerging growth company upon the earliest of: (i) the last day of the first fiscal year in which our annual gross revenues are $1.07 billion or more; (ii) the end of any fiscal year in which the market value of our common stock held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year; or (iii) the date on which we have, during the previous three-year period, issued more than $1.07 billion in non-convertible debt securities.
We will remain an emerging growth company until the earliest of: (i) the last day of the fiscal year in which our annual gross revenues exceed $1.235 billion; (ii) the last day of the fiscal year in which the market value of our common stock held by non-affiliates exceeds $700 million as of the end of the second quarter of that fiscal year; (iii) the date on which we have issued more than $1.0 billion in non-convertible debt during the previous three-year period; or (iv) the last day of the fiscal year following the fifth anniversary of our initial public offering.
We may record a return reserve for anticipated returns related to these sales programs at the time of the sale based on the terms of the sales program. 35 Stock-Based Compensation The Company periodically issues stock options to employees and non-employees in non-capital raising transactions for services and for financing costs.
We may record a return reserve for anticipated returns related to these sales programs at the time of the sale based on the terms of the sales program. 43 Stock-Based Compensation The Company periodically grants restricted stock units (“RSUs”) and stock options to employees, directors, and consultants as compensation for services.
These estimates and assumptions include a number of objective and subjective factors, including external market conditions, guideline public company information, the prices at which the Company sold its common stock to third parties in arms’ length transactions, the rights and preferences of securities senior to the Company’s common stock at the time, and the likelihood of achieving a liquidity event such as an initial public offering or sale.
These valuations incorporated various objective and subjective factors, including external market conditions, guideline public company information, arm’s-length transactions involving the Company’s securities, the rights and preferences of securities senior to the Company’s common stock, and the probability of achieving a liquidity event such as an initial public offering or sale of the Company.
The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period.
The Company accounts for these awards in accordance with ASC 718, Compensation—Stock Compensation, whereby the fair value of the award is measured on the grant date and recognized as compensation expense on a straight-line basis over the vesting period. Stock-based compensation expense is recorded within the Company’s consolidated statements of operations based on the nature of the services rendered.
As a result, the Company may adopt new or revised accounting standards by the date private companies are required to comply. Off-Balance Sheet Arrangements At December 31, 2024 and 2023, the Company did not have any transactions, obligations or relationships that could be considered off-balance sheet arrangements.
Off-Balance Sheet Arrangements At December 31, 2025 and 2024, the Company did not have any transactions, obligations or relationships that could be considered off-balance sheet arrangements.
The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business.
Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. 41 As reflected in the accompanying financial statements, during the year ended December 31, 2025, the Company incurred a net loss of $6,020,000 and used cash in operations of $5,166,000.
The decrease in net cash used in operations for the year ended December 31, 2024, was primarily related to cash used to repay our accrued payroll to officers. Investing Activities Net cash used in investing activities for the year ended December 31, 2024 totalled $502,000, and was for the purchase of property and equipment.
Investing Activities Net cash used in investing activities for the year ended December 31, 2025 totaled $469,000, primarily related to purchases of property and equipment associated with the expansion and support of the Company’s manufacturing operations. Net cash used in investing activities for the year ended December 31, 2024 totaled $502,000, also related primarily to purchases of property and equipment.
Comparison of the Year Ended December 31, 2024 Compared to the Year Ended December 31, 2023 Our sales, cost of goods sold, operating expenses, and net loss from operations for the year ended December 31, 2024, as compared to the year ended December 31, 2023 were as follows (amounts are rounded to nearest thousands): Year Ended December 31, 2024 Year Ended December 31, 2023 % Change Net Sales $ 3,445,000 $ 349,000 887 % Cost of goods sold 1,171,000 227,000 416 % Gross profit 2,274,000 122,000 1,764 % Operating expenses: Selling, general and administrative 6,509,000 4,497,000 45 % Research and development 743,000 258,000 188 % Total operating expenses 7,252,000 4,755,000 53 % Loss from operations (4,978,000 ) (4,633,000 ) 7 % Interest income (expense), net 161,000 8,000 1,900 % Financing costs (6,913,000 ) - 100 % Change in fair value of warrant liability (22,000 ) - 100 % Net loss $ (11,752,000 ) $ (4,625,000 ) 154 % 31 Net Sales Our net sales increased $3.1 million, or 887%, to approximately $3.5 million during the year ended December 31, 2024, compared to $349,000 during the year ended December 31, 2023.
Comparison of the Year Ended December 31, 2025 Compared to the Year Ended December 31, 2024 Our sales, cost of goods sold, operating expenses, and net loss from operations for the year ended December 31, 2025, as compared to the year ended December 31, 2024 were as follows (amounts are rounded to nearest thousands): Year Ended December 31, 2025 Year Ended December 31, 2024 $ Changes Net Sales $ 8,135,000 $ 3,445,000 $ 4,690,000 Cost of goods sold 3,581,000 1,171,000 2,410,000 Gross profit 4,554,000 2,274,000 2,280,000 Operating expenses: Selling, general and administrative 11,323,000 6,509,000 4,814,000 Research and development 779,000 743,000 36,000 Total operating expenses 12,102,000 7,252,000 4,850,000 Loss from operations (7,548,000 ) (4,978,000 ) (2,570,000 ) Interest income, net 99,000 161,000 (62,000 ) Financing costs - (6,913,000 ) 6,913,000 Change in fair value of warrant liability 1,429,000 (22,000 ) 1,451,000 Net loss $ (6,020,000 ) $ (11,752,000 ) $ 5,732,000 Overview of Operating Results The Company’s operating results for the year ended December 31, 2025 were primarily driven by the following factors: ● Expansion of the Newton Motion shaft product line.
Management expects its cash on hand on December 31, 2024, to last for at least the next 12 months. The continuation of the Company as a going concern is dependent upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow.
Management currently expects that its existing cash resources will fund operations for a limited period and that additional financing will be required to support ongoing operations. The continuation of the Company as a going concern is dependent upon its ability to obtain additional debt or equity financing until it begins generating positive cash flow.
Emerging Growth Company We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, which we refer to as the JOBS Act.
Emerging Growth Company We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As an emerging growth company, we are eligible to take advantage of certain exemptions from various reporting requirements applicable to other public companies.
Liquidity and Capital Resources The following table summarizes our cash flows for the periods indicated (amounts are rounded to nearest thousands): Year Ended December 31, 2024 2023 Net cash provided by (used in): Operating activities $ (4,929,000 ) $ (5,047,000 ) Investing activities (502,000 ) (289,000 ) Financing activities 7,743,000 10,503,000 Net increase in cash $ 2,312,000 $ 5,167,000 Operating Activities Net cash used in operating activities for the year ended December 31, 2024 totalled $4,929,000, compared to net cash used in operating activities for the year ended December 31, 2023 of $5,047,000.
The Company expects that only modest capital investments may be required to enhance production capacity and operational efficiency as demand for Newton products continues to grow. 40 The following table summarizes our cash flows for the periods indicated (amounts are rounded to nearest thousands): Year Ended December 31, 2025 2024 Net cash (used in) provided by: Operating activities $ (5,166,000 ) $ (4,929,000 ) Investing activities (469,000 ) (502,000 ) Financing activities (717,000 ) 7,743,000 Net (decrease) increase in cash $ (6,352,000 ) $ 2,312,000 Operating Activities Net cash used in operating activities for the year ended December 31, 2025 was $5,166,000, compared to $4,929,000 for the year ended December 31, 2024.
For the year ended December 31, 2024, we generated $2.9 million of net sales from the Newton Motion shafts, and we generated approximately 84% of our net sales through our websites. Cost of goods sold Cost of goods sold represents primarily our material, labor, components, and changes in inventory reserves for slow-moving or potentially obsolete products.
Cost of goods sold Cost of goods sold consists primarily of materials, labor, components, and changes in inventory reserves for slow-moving or potentially obsolete products. Cost of goods sold increased by approximately $2.4 million to $3.6 million for the year ended December 31, 2025, compared to $1.2 million for the year ended December 31, 2024.
The expected dividend yield is zero, based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. Prior to August 14, 2023, the common shares of the Company were not publicly traded.
Treasury yield curve in effect at the time of grant for time periods approximately equal to the expected term of the award. The expected dividend yield is zero, based on the fact that the Company has never paid dividends and does not currently expect to pay dividends in the foreseeable future.
The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company’s control, among other conditions for equity classification.
In particular, the Company assesses whether the warrants are indexed to the Company’s own stock and whether the terms of the warrants could require net cash settlement in circumstances outside the Company’s control, among other conditions required for equity classification.
As reflected in the accompanying financial statements, during the year ended December 31, 2024, we incurred a net loss of $11,752,000 and used cash in operations of $4,929,000. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date of the financial statements being issued.
These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financial statements are issued.
The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award.
The expected term of stock options granted to employees is determined using the “simplified method” for awards that qualify as plain-vanilla options. The expected term of stock options granted to non-employees is generally based on the contractual term of the award. The risk-free interest rate is determined by reference to the U.S.
No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company.
No assurance can be given that such financing will be available or, if available, that it will be on terms acceptable to the Company. Any additional financing may contain restrictive covenants, in the case of debt financing, or result in substantial dilution to existing stockholders, in the case of equity financing.
Impact of Inflation Recent inflationary trends have led to a moderate increase in some of the component parts used to manufacture our products. To date, we have not passed the increase in cost to our consumers.
Impact of Inflation Inflation has resulted in moderate increases in the cost of certain raw materials and component parts used in the manufacture of our products. To date, we have largely absorbed these increases and have not significantly raised prices.
Interest income, net was $161,000 for the year ended December 31, 2024, compared to interest income, net of $8,000 for the year ended December 31, 2023.
As revenue continues to scale, the Company expects to benefit from improved operating leverage over time. Other income (expense), net Interest income, net was $99,000 for the year ended December 31, 2025, compared to $161,000 for the year ended December 31, 2024.
Selling, general and administrative expenses include employee costs, legal and professional fees, sales and marketing expenses, stock-based compensation, public company expenses, rent, depreciation and other general expenses. Our selling, general and administrative expenses increased approximately $2.0 million to $6.5 million during the year ended December 31, 2024, compared to $4.5 million during the year ended December 31, 2023.
Selling, general and administrative expenses increased approximately $4.8 million to $11.3 million for the year ended December 31, 2025, compared to $6.5 million for the year ended December 31, 2024.
Loss from operations Loss from operations increased to $5.0 million for the year ended December 31, 2024, compared to $4.6 million for the year ended December 31, 2023. The increase in our net loss was due to our increased operating expenses, offset by increased gross profit, as discussed above.
Loss from operations Loss from operations increased approximately $2.5 million to $7.5 million for the year ended December 31, 2025, compared to $5.0 million for the year ended December 31, 2024.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. Recently Issued Accounting Pronouncements See Note 2 of the Notes to Condensed Financial Statements for a discussion of recent accounting pronouncements.
This assessment requires the use of professional judgment and is performed at the time of warrant issuance and reassessed at each reporting period while the warrants remains outstanding.
Net cash used in investing activities for the year ended December 31, 2023 totaled $289,000, and was for the purchase of property and equipment.
Financing Activities Net cash used in financing activities for the year ended December 31, 2025 was $717,000, compared to net cash provided by financing activities of $7,743,000 for the year ended December 31, 2024. The net cash used in financing activities during 2025 primarily reflected cash used for share repurchases and other financing-related activities during the year.
As such, during the period, the Company estimated the fair value of common stock using an appropriate valuation methodology, in accordance with the framework of the American Institute of Certified Public Accountants’ Technical Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation. Each valuation methodology includes estimates and assumptions that require the Company’s judgment.
Prior to the Company’s initial public offering on August 14, 2023, the Company’s common stock was not publicly traded. As a result, the Company estimated the fair value of its common stock using valuation methodologies consistent with the framework outlined in the AICPA Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation.
On April 4, 2024, we announced another expansion of our product portfolio, the Newton Motion fairway wood shaft, which like the Newton Motion driver shaft discussed above, is a carbon fiber shaft designed to enhance a golfer’s performance by promoting straighter and longer shots with reduced effort.
The Newton Motion driver shaft is a carbon fiber golf shaft designed to improve performance and consistency for golfers. In April 2024, the Company further expanded its product line with the introduction of the Newton Motion fairway wood shaft.
Management believes the critical accounting estimates discussed below affect its more significant estimates and assumptions used in the preparation of its consolidated financial statements.
Management evaluates its estimates on an ongoing basis and adjusts those estimates when facts and circumstances change. Management believes the following accounting policies involve the most significant judgments and estimates used in the preparation of the Company’s financial statements.
Other income (expense), net During the year ended December 31, 2024, the Company recorded financing cost of $6,913,000 and a change in the fair value of warrant liabilities of $22,000 (see Note 8 of the accompanying financial statements), both of which did not occur in the prior year period.
During the year ended December 31, 2025, the Company recognized a $1.4 million gain related to the change in the fair value of warrant liabilities, compared to a $22,000 loss recognized during the year ended December 31, 2024.
Research and development costs include employee costs, consultants, licensing fees, and product design and development costs. Research and development expenses increased $485,000 to $742,000 during the year ended December 31, 2024, compared to $258,000 during the year ended December 31, 2023.
Research and development expenses increased approximately $0.04 million to $0.8 million, or 5%, for the year ended December 31, 2025, compared to $0.7 million for the year ended December 31, 2024.